Potential role of plasmacytoid dendritic cells for FOXP3+ regulatory T cell development in human colorectal cancer and tumor draining lymph node

Pathology Research and Practice

Volumn 209, Issue 12, 2013, Pages 774-778

  Gai, Xiao Dong ^a   Song, Yang ^a   Li, Chun ^a   Lei, Yan Ming ^b   Yang, Baoxue ^c  

^a BEIHUA UNIVERSITY   (China)

^b General Hospital of CNPC in Jilin   (China)

^c PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

Colorectal cancer; Immunohistochemistry; Plasmacytoid dentritic cells; Regulatory T cells; Tumor draining lymph nodes

Indexed keywords

CD123 ANTIGEN; TRANSCRIPTION FACTOR FOXP3;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CELL ASSAY; CELL MATURATION; COLON CANCER; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE; LYMPH NODE METASTASIS; LYMPHOCYTIC INFILTRATION; MAJOR CLINICAL STUDY; MALE; MOLECULAR PATHOLOGY; PLASMACYTOID DENDRITIC CELL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; TUMOR DRAINING LYMPH NODE; TUMOR MICROENVIRONMENT;

COLORECTAL CANCER; IMMUNOHISTOCHEMISTRY; PLASMACYTOID DENTRITIC CELLS; REGULATORY T CELLS; TUMOR DRAINING LYMPH NODES;

AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; DENDRITIC CELLS; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; T-LYMPHOCYTES, REGULATORY;

EID: 84887817927     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2013.08.011     Document Type: Article

References (36)

1. Hori S., Nomura T., Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003, 299:1057-1061.
2. + regulatory T cells. Nat. Immunol. 2003, 4:330-336.
3. + T regulatory cells. Nat. Immunol. 2003, 4:337-342.
4. + regulatory T cells in tumor immunity. Curr. Top. Microbiol. Immunol. 2005, 293:287-302.
5. Cochran A.J., Huang R.R., Lee J., Itakura E., Leong S.P., Essner R. Tumor-induced immune modulation of sentinel lymph nodes. Nat. Rev. Immunol. 2006, 6:659-670.
6. Munn D.H., Mellor A.L. The tumor-draining lymph node as an immune-privileged site. Immunol. Rev. 2006, 213:146-158.
7. Sun C.M., Hall J.A., Blank R.B., Bouladoux N., Oukka M., Mora J.R., Belkaid Y. Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 Treg cells via retinoic acid. J. Exp. Med. 2007, 204:1775-1785.
8. Palucka K., Ueno H., Fay J., Banchereau J. Dendritic cells and immunity against cancer. J. Intern. Med. 2011, 269:64-73.
9. Hubert P., Jacobs N., Caberg J.H., Boniver J., Delvenne P. The cross-talk between dendritic and regulatory T cells, good or evil?. J. Leukoc. Biol. 2007, 82:781-794.
10. + regulatory T cells and myeloid dentritic cells in human colorectal cancer and tumor draining lymph node. Biomed. Rep. 2013, 1:207-212.
11. Matta B.M., Castellaneta A., Thomson A.W. Tolerogenic plasmacytoid DC. Eur. J. Immunol. 2010, 40:2667-2676.
12. + regulatory T cells. J. Immunol. 2004, 173:4433-4442.
13. Ito T., Yang M., Wang Y.H., Lande R., Gregorio J., Perng O.A., Qin X.F., Liu Y.J., Gilliet M. Plasmacytoid dendritic cells prime IL-10-producing T regulatory cells by inducible costimulator ligand. J. Exp. Med. 2007, 204:105-115.
14. Brunkow M.E., Jeffery E.W., Hjerrild K.A., Paeper B., Clark L.B., Yasayko S.A., Wilkinson J.E., Galas D., Ziegler S.F., Ramsdell F. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat. Genet. 2001, 27:68-73.
15. + T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer. Cancer Res. 2001, 61:4766-4772.
16. Liyanage U.K., Moore T.T., Joo H.G., Tanaka Y., Herrmann V., Doherty G., Drebin J.A., Strasberg S.M., Eberlein T.J., Goedegebuure P.S., Linehan D.C. Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma. J. Immunol. 2002, 169:2756-2761.
17. Curiel T.J., Coukos G., Zou L., Alvarez X., Cheng P., Mottram P., Evdemon-Hogan M., Conejo-Garcia J.R., Zhang L., Burow M., Zhu Y., Wei S., Kryczek I., Daniel B., Gordon A., Myers L., Lackner A., Disis M.L., Knutson K.L., Chen L., Zou W. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat. Med. 2004, 10:942-949.
18. high regulatory T cells are overrepresented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells. J. Immunol. 2004, 173:1444-1453.
19. + regulatory T cells and their ligands: implications for immunotherapy. Immunity 2004, 20:107-118.
20. + regulatory T cells. J. Immunol. 2005, 174:2661-2670.
21. +/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:18538-18543.
22. -lymphocytes is thymus and proliferation in dependent. Cancer Res. 2006, 66:4488-4495.
23. Rolle C.E., Sengupta S., Lesniak M.S. Mechanisms of immune evasion by gliomas. Adv. Exp. Med. Biol. 2012, 746:53-76.
24. Zou W. Immunosuppressive networks in the tumour environment and their therapeutic relevance. Nat. Rev. Cancer 2005, 5:263-274.
25. Liu J., Lu G., Li Z., Tang F., Liu Y., Cui G. Distinct compartmental distribution of mature and immature dendritic cells in esophageal squamous cell carcinoma. Pathol. Res. Pract. 2010, 206:602-606.
26. Hartmann E., Wollenberg B., Rothenfusser S., Wagner M., Wellisch D., Mack B., Giese T., Gires O., Endres S., Hartmann G. Identification and functional analysis of tumor-infiltrating plasmacytoid dendritic cells in head and neck cancer. Cancer Res. 2003, 63:6478-6487.
27. Gerlini G., Urso C., Mariotti G., Di Gennaro P., Palli D., Brandani P., Salvadori A., Pimpinelli N., Reali U.M., Borgognoni L. Plasmacytoid dendritic cells represent a major dendritic cell subset in sentinel lymph nodes of melanoma patients and accumulate in metastatic nodes. Clin. Immunol. 2007, 125:184-193.
28. Perrot I., Blanchard D., Freymond N., Isaac S., Guibert B., Pachéco Y., Lebecgue S. Dendritic cells infiltrating human non-small cell lung cancer are blocked at immature stage. J. Immunol. 2007, 178:2763-2769.
29. + plasmacytoid dendritic cells in human melanoma sentinel nodes. J. Invest. Dermatol. 2010, 130:898-901.
30. Battaglia A., Buzzonetti A., Baranello C., Ferrandina G., Martinelli E., Fanfani F., Scambia G., Fattorossi A. Metastatic tumour cells favour the generation of a tolerogenic milieu in tumour draining lymph node in patients with early cervical cancer. Cancer Immunol. Immunother. 2009, 58:1363-1373.
31. Kanazawa M., Yoshihara K., Abe H., Iwadate M., Watanabe K., Suzuki S., Endoh Y., Takita K., Sekikawa K., Takenoshita S., Ogata T., Ohto H. Effects of PSK on T and dendritic cells differentiation in gastric or colorectal cancer patients. Anticancer Res. 2005, 25:443-449.
32. Cox K., North M., Burke M., Singhal H., Renton S., Agel N., Islam S., Knight S.C. Plasmacytoid dendritic cells (PDC) are the major DC subset innately producing cytokines in human lymph nodes. J. Leukoc. Biol. 2005, 78:1142-1152.
33. Zou W., Machelon V., Coulomb-L'Hermin A., Borvak J., Nome F., Isaeva T., Wei S., Krzysiek R., Durand-Gasselin I., Gordon A., Pustilnik T., Curiel D.T., Galanaud P., Capron F., Emilie D., Curiel T.J. Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells. Nat. Med. 2001, 7:1339-1346.
34. Lande R., Gilliet M. Plasmacytoid dendritic cells: key players in the initiation and regulation of immune responses. Ann. N.Y. Acad. Sci. 2010, 1183:89-103.
35. Sharma M.D., Baban B., Chandler P., Hou D.Y., Singh N., Yagita H., Azuma M., Blazar B.R., Mellor A.L., Munn D.H. Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase. J. Clin. Invest. 2007, 117:2570-2582.
36. Ochando J.C., Homma C., Yang Y., Hidalgo A., Garin A., Tacke F., Angeli V., Li Y., Boros P., Ding Y., Jessberger R., Trinchieri G., Lira S.A., Randolph G.J., Bromberg J.S. Alloantigen-presenting plasmacytoid dendritic cells mediate tolerance to vascularized grafts. Nat. Immunol. 2006, 7:652-662.